Dolby Laboratories (NYSE:DLB – Get Free Report) CAO Ryan Nicholson sold 357 shares of the company’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $60.63, for a total value of $21,644.91. Following the completion of the transaction, the chief accounting officer directly owned 36,984 shares of the company’s stock, valued at approximately $2,242,339.92. This trade represents a 0.96% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Dolby Laboratories Stock Down 0.8%
DLB stock traded down $0.49 during mid-day trading on Thursday, hitting $60.87. The company had a trading volume of 1,132,331 shares, compared to its average volume of 828,452. The company has a 50-day moving average price of $52.59 and a 200 day moving average price of $58.48. Dolby Laboratories has a 12-month low of $48.26 and a 12-month high of $75.66. The company has a market capitalization of $5.76 billion, a price-to-earnings ratio of 25.90 and a beta of 0.80.
Dolby Laboratories (NYSE:DLB – Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The electronics maker reported $0.69 earnings per share for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. The firm had revenue of $305.00 million during the quarter, compared to analyst estimates of $311.96 million. Dolby Laboratories had a return on equity of 11.08% and a net margin of 16.70%.The business’s quarterly revenue was down 3.3% compared to the same quarter last year. During the same quarter last year, the business posted $0.78 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. As a group, analysts expect that Dolby Laboratories will post 3.21 EPS for the current year.
Dolby Laboratories Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, August 19th. Shareholders of record on Tuesday, August 11th will be paid a $0.36 dividend. The ex-dividend date is Tuesday, August 11th. This represents a $1.44 dividend on an annualized basis and a yield of 2.4%. Dolby Laboratories’s dividend payout ratio (DPR) is presently 61.28%.
Analyst Upgrades and Downgrades
DLB has been the topic of several research analyst reports. Barrington Research reissued an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a research note on Monday, June 15th. Rosenblatt Securities reaffirmed a “buy” rating and set a $85.00 target price on shares of Dolby Laboratories in a research report on Friday, July 31st. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Wednesday, June 24th. Finally, Wall Street Zen downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $90.75.
Check Out Our Latest Report on Dolby Laboratories
Hedge Funds Weigh In On Dolby Laboratories
Large investors have recently added to or reduced their stakes in the company. Royal Bank of Canada grew its position in shares of Dolby Laboratories by 3.5% in the 1st quarter. Royal Bank of Canada now owns 68,367 shares of the electronics maker’s stock worth $5,491,000 after buying an additional 2,298 shares during the last quarter. Goldman Sachs Group Inc. boosted its stake in Dolby Laboratories by 218.8% in the first quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker’s stock valued at $20,043,000 after acquiring an additional 171,288 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Dolby Laboratories by 5.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 238,216 shares of the electronics maker’s stock valued at $19,131,000 after acquiring an additional 12,598 shares in the last quarter. Focus Partners Wealth purchased a new position in Dolby Laboratories in the first quarter worth $390,000. Finally, EverSource Wealth Advisors LLC increased its position in shares of Dolby Laboratories by 273.3% during the second quarter. EverSource Wealth Advisors LLC now owns 2,598 shares of the electronics maker’s stock worth $193,000 after purchasing an additional 1,902 shares in the last quarter. 58.56% of the stock is currently owned by institutional investors.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Featured Articles
- Five stocks we like better than Dolby Laboratories
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
